{"transactions":[{"id":706426,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:13:46.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":60833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the options on July 16, 2027, the first anniversary of the grant date, and as to the remaining 50% of the options on July 16, 2028, the second anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":60833,"derivative":{"exercise_price":3.2,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":60833},"source":{"system":"sec-edgar","filing":"0001787403-26-000002","document":"wk-form4_1784319224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000178740326000002/wk-form4_1784319224.xml","form_type":"4"}},{"id":921041,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-03T21:40:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":47900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":47900,"derivative":{"exercise_price":8.1,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":47900},"source":{"system":"sec-edgar","filing":"0001601485-26-000008","document":"wk-form4_1770154812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000008/wk-form4_1770154812.xml","form_type":"4"}},{"id":921040,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-03T21:40:15.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001601485-26-000008","document":"wk-form4_1770154812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148526000008/wk-form4_1770154812.xml","form_type":"4"}},{"id":1170847,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-16T21:12:23.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":191624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the options on March 24, 2025, the first anniversary of the Reporting Person's start date, with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":191624,"derivative":{"exercise_price":4.98,"expiration_date":"2035-04-15","underlying":"Common Stock","underlying_shares":191624},"source":{"system":"sec-edgar","filing":"0001601485-25-000065","document":"wk-form4_1744837936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148525000065/wk-form4_1744837936.xml","form_type":"4"}},{"id":1393699,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-02T17:19:12.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":130087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of September 30, 2024."}],"balance_after":130087,"derivative":{"exercise_price":10.75,"expiration_date":"2034-09-29","underlying":"Common Stock","underlying_shares":130087},"source":{"system":"sec-edgar","filing":"0001610618-24-000131","document":"wk-form4_1727903945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061824000131/wk-form4_1727903945.xml","form_type":"4"}},{"id":1565706,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-20T18:48:19.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":217500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024."}],"balance_after":217500,"derivative":{"exercise_price":0.6849,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":217500},"source":{"system":"sec-edgar","filing":"0001610618-24-000026","document":"wk-form4_1710974888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061824000026/wk-form4_1710974888.xml","form_type":"4"}},{"id":1565705,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2024-03-20T18:48:19.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":108750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date."}],"balance_after":335960,"source":{"system":"sec-edgar","filing":"0001610618-24-000026","document":"wk-form4_1710974888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061824000026/wk-form4_1710974888.xml","form_type":"4"}},{"id":1580155,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2024-03-12T21:45:37.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":18931,"price":0.6698,"value":12679.9838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.66 to $0.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on May 19, 2023 and November 20, 2023."}],"balance_after":227210,"source":{"system":"sec-edgar","filing":"0001610618-24-000009","document":"wk-form4_1710294327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061824000009/wk-form4_1710294327.xml","form_type":"4"}},{"id":1935506,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-29T17:24:31.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023."}],"balance_after":180000,"derivative":{"exercise_price":1.01,"expiration_date":"2033-03-26","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001610618-23-000028","document":"wf-form4_168012506014993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061823000028/wf-form4_168012506014993.xml","form_type":"4"}},{"id":1935505,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2023-03-29T17:24:31.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date."}],"balance_after":238141,"source":{"system":"sec-edgar","filing":"0001610618-23-000028","document":"wf-form4_168012506014993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061823000028/wf-form4_168012506014993.xml","form_type":"4"}},{"id":1956327,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2023-03-13T21:20:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":6648,"price":1.53,"value":10171.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (\"ESPP\") on November 18, 2022."}],"balance_after":148141,"source":{"system":"sec-edgar","filing":"0001610618-23-000011","document":"wf-form4_167875683891628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061823000011/wf-form4_167875683891628.xml","form_type":"4"}},{"id":2155022,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Restricted Stock Unit","published_at":"2022-09-19T20:28:21.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2021, the Reporting Person was granted restricted stock units totaling 50,000 shares subject to vesting upon the achievement of various milestones."}],"balance_after":0,"derivative":{"expiration_date":"2022-09-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001610618-22-000081","document":"wf-form4_166363368557923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000081/wf-form4_166363368557923.xml","form_type":"4"}},{"id":2155021,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2022-09-19T20:28:21.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":15642,"price":0.7694,"value":12034.9548,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 15, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":150789,"source":{"system":"sec-edgar","filing":"0001610618-22-000081","document":"wf-form4_166363368557923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000081/wf-form4_166363368557923.xml","form_type":"4"}},{"id":2155020,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2022-09-19T20:28:21.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on September 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022."}],"balance_after":166431,"source":{"system":"sec-edgar","filing":"0001610618-22-000081","document":"wf-form4_166363368557923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000081/wf-form4_166363368557923.xml","form_type":"4"}},{"id":2307157,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-04T17:21:45.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":102500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022."}],"balance_after":102500,"derivative":{"exercise_price":0.83,"expiration_date":"2032-03-30","underlying":"Common Stock","underlying_shares":102500},"source":{"system":"sec-edgar","filing":"0001610618-22-000029","document":"wf-form4_164910727375649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000029/wf-form4_164910727375649.xml","form_type":"4"}},{"id":2307156,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2022-04-04T17:21:45.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":24820,"price":0.83,"value":20600.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld for taxes on RSU vesting."}],"balance_after":112431,"source":{"system":"sec-edgar","filing":"0001610618-22-000029","document":"wf-form4_164910727375649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000029/wf-form4_164910727375649.xml","form_type":"4"}},{"id":2307155,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2022-04-04T17:21:45.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":66001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date."}],"balance_after":137251,"source":{"system":"sec-edgar","filing":"0001610618-22-000029","document":"wf-form4_164910727375649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000029/wf-form4_164910727375649.xml","form_type":"4"}},{"id":2307154,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2022-04-04T17:21:45.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":51250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022.  All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date."}],"balance_after":71250,"source":{"system":"sec-edgar","filing":"0001610618-22-000029","document":"wf-form4_164910727375649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061822000029/wf-form4_164910727375649.xml","form_type":"4"}},{"id":2512247,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2021-11-15T18:38:04.000Z","date":"2021-11-12","kind":"purchase","acquired":true,"shares":20000,"price":1.54,"value":30800.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001610618-21-000106","document":"wf-form4_163701945046603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061821000106/wf-form4_163701945046603.xml","form_type":"4"}},{"id":2578383,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Restricted Stock Unit","published_at":"2021-09-03T16:32:11.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU will fully vest upon the completion of certain corporate milestones on or before September 30, 2022."}],"balance_after":50000,"derivative":{"expiration_date":"2022-09-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001610618-21-000082","document":"wf-form4_163070111456972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061821000082/wf-form4_163070111456972.xml","form_type":"4"}},{"id":2578382,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-03T16:32:11.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":311850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of September 1, 2021; 1/48th of the shares subject to the option shall vest monthly thereafter,such that all shares will be vested on September 1, 2025."}],"balance_after":311850,"derivative":{"exercise_price":2.22,"expiration_date":"2031-08-31","underlying":"Common Stock","underlying_shares":311850},"source":{"system":"sec-edgar","filing":"0001610618-21-000082","document":"wf-form4_163070111456972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610618/000161061821000082/wf-form4_163070111456972.xml","form_type":"4"}},{"id":2927902,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2021-01-01T02:20:04.000Z","date":"2020-12-30","kind":"tax_withholding","acquired":false,"shares":25000,"price":4.64,"value":116000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of a previously reported restricted stock award."}],"balance_after":11600,"source":{"system":"sec-edgar","filing":"0001104659-20-141128","document":"tm2039739-1d4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465920141128/tm2039739-1d4.xml","form_type":"4"}},{"id":3330543,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-12-27T12:01:19.000Z","date":"2019-12-24","kind":"purchase","acquired":true,"shares":11600,"price":3.9594,"value":45929.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.89 to $3.9789, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":36600,"source":{"system":"sec-edgar","filing":"0001104659-19-076290","document":"tm1927404-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000110465919076290/tm1927404-2_4.xml","form_type":"4"}},{"id":3419701,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-09T12:00:43.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option shall vest and become exercisable as to 25% of the underlying shares on the first anniversary of the date of grant, and the remaining shares underlying the option shall vest and become exercisable in equal quarterly installments thereafter, until fully vested and exercisable on the fourth anniversary of the date of grant, provided Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":6,"exercise_date":"2020-09-06","expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-19-043864","document":"tv529006_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043864/tv529006_4.xml","form_type":"4"}},{"id":3419700,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-09T12:00:43.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option shall vest and become exercisable as to 25% of the underlying shares on the first anniversary of the date of grant, and the remaining shares underlying the option shall vest and become exercisable in equal quarterly installments thereafter, until fully vested and exercisable on the fourth anniversary of the date of grant, provided Reporting Person remains employed by Issuer from the date of grant through each applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":3.96,"exercise_date":"2020-09-06","expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001144204-19-043864","document":"tv529006_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043864/tv529006_4.xml","form_type":"4"}},{"id":3419699,"issuer":{"id":7869,"kind":"organization","name":"BRAINSTORM CELL THERAPEUTICS INC."},"owners":[{"id":29685,"kind":"person","name":"Shah Preetam","position":1,"cik":"0001787403","reported_name":"Shah Preetam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2019-09-09T12:00:43.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired are shares of restricted stock awarded on September 6, 2019 under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 100% of the award on September 6, 2020, provided that the Reporting Person remains continuously employed by Issuer from the date of grant through the vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001144204-19-043864","document":"tv529006_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1137883/000114420419043864/tv529006_4.xml","form_type":"4"}}]}